Equities researchers at HC Wainwright started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO) in a note issued to investors on Monday, The Fly reports. The firm set a “buy” rating on the stock.
Taro Pharmaceutical Industries (TARO) opened at $100.18 on Monday. Taro Pharmaceutical Industries has a fifty-two week low of $93.01 and a fifty-two week high of $128.46. The stock has a market capitalization of $4,017.42, a P/E ratio of 19.45 and a beta of 0.64.
A number of hedge funds and other institutional investors have recently modified their holdings of TARO. Wells Fargo & Company MN boosted its stake in Taro Pharmaceutical Industries by 11.2% during the 2nd quarter. Wells Fargo & Company MN now owns 1,685 shares of the company’s stock valued at $189,000 after purchasing an additional 170 shares in the last quarter. ARK Investment Management LLC bought a new position in Taro Pharmaceutical Industries during the 4th quarter valued at $247,000. Scotia Capital Inc. bought a new position in Taro Pharmaceutical Industries during the 4th quarter valued at $265,000. Parametrica Management Ltd bought a new position in Taro Pharmaceutical Industries during the 4th quarter valued at $306,000. Finally, Tower Research Capital LLC TRC boosted its stake in Taro Pharmaceutical Industries by 176.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,995 shares of the company’s stock valued at $314,000 after purchasing an additional 1,913 shares in the last quarter. 12.26% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: “Taro Pharmaceutical Industries (TARO) Coverage Initiated at HC Wainwright” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3257024/taro-pharmaceutical-industries-taro-coverage-initiated-at-hc-wainwright.html.
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.
Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.